2015 Peel Street
QC H3A 1T8
Canada - Map
Theratechnologies Inc., specialty pharmaceutical company, addresses unmet medical needs in metabolic disorders. The companys lead product is EGRIFTA (tesamorelin for injection), an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in the United States. It also focuses on commercializing EGRIFTA in Latin America, Africa, the Middle East, Europe, Russia, South Korea, Taiwan, Thailand, and certain central Asian countries. The company was founded in 1993 and is headquartered in Montreal, Canada.
|Mr. Luc Tanguay M.Sc., C.F.A.,
Chief Exec. Officer, Pres and Non-Independent Director
|Ms. Marie-NoÃ«l Colussi C.A.,
VP of Fin.
|Mr. Jocelyn Lafond LL.B., L.L.M.,
VP of Legal Affairs and Corp. Sec.
|Mr. Christian Marsolais Ph.D.,
Sr. VP of Medical Affairs
|Ms. Lyne Fortin MBA, B.Pharm.,
Sr. Chief Commercial Officer and Sr. VP
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in CAD.|